ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases

M A Olayioye1, I Beuvink, K Horsch

  • 1Friedrich Miescher Institute, P.O. Box 2543, CH-4002 Basel, Switzerland.

Insights

Epidermal growth factor (EGF) receptor signaling activates signal transducer and activator of transcription (Stat) factors. Src kinases, not Janus kinases, mediate EGF-induced Stat activation and receptor complex formation.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Oncology

Background:

  • Epidermal growth factor (EGF) binding to its receptor, ErbB1, initiates signal transduction pathways.
  • The precise mechanisms of ErbB1-mediated Stat activation and the roles of other ErbB receptors remain unclear.

Purpose of the Study:

  • To elucidate the mechanism of ErbB1-induced Stat activation.
  • To investigate whether Stats are downstream targets of other ErbB receptors.
  • To identify the kinases involved in EGF-mediated Stat activation.

Main Methods:

  • Utilized A431 cells for experiments.
  • Investigated Stat factor phosphorylation and complex formation with ErbB receptors.
  • Employed Src kinase inhibitors and dominant-negative constructs for kinase analysis.

Main Results:

  • ErbB2, ErbB3, and ErbB4 did not enhance EGF-induced Stat5 phosphorylation, but ErbB2/ErbB4 heterodimers activated Stat5 upon neu differentiation factor stimulation.
  • Stat1, Stat3, and Stat5 constitutively associated with ErbB1 and were tyrosine phosphorylated upon EGF stimulation.
  • EGF- and neu differentiation factor-induced Stat activation were dependent on Src kinases, not Janus kinases.
  • Src kinases were recruited to Stat/ErbB receptor complexes upon EGF stimulation.
  • Src kinase inhibition or blockade ablated Stat and Jak tyrosine phosphorylation.

Conclusions:

  • Src kinases play a dual role in ErbB receptor-mediated Stat signaling, acting as key mediators and potential upstream regulators of Janus kinases.
  • EGF-induced Stat activation is primarily mediated by Src kinases, independent of Janus kinases.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...